Results 71 to 80 of about 1,469,179 (291)
Table of Contents, Volume 4, Number 3, 2006 [PDF]
The articles in this issue are devoted to the practice of law in New ...
Editorial Board
core +2 more sources
Fragmented Self: Hawthorne’s Prescient Eye in “The Prophetic Pictures” and “Wakefield” [PDF]
This brief essay intends to shed a fresh light on two short stories written by the celebrated American author Nathaniel Hawthorne from the perspective of how the ‘self’ is explored; the works to be discussed are “The Prophetic Pictures” and “Wakefield ...
Naruhiko Mikado
doaj +1 more source
FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium
ABSTRACT Background and Objectives Spinocerebellar ataxias (SCA) represent a clinically and genetically heterogeneous group of progressive neurodegenerative diseases with prominent cerebellar atrophy. Recently, a novel pathogenic repeat expansion in intron 1 of FGF14 was identified, causing adult‐onset SCA (SCA27B). We aimed to determine the proportion
Alexanne Cuillerier+20 more
wiley +1 more source
Functional Programming is Free [PDF]
A paper has recently been published in SIAM-JC. This paper is faulty: 1) The standard requirements about the definition of an algorithm are not respected, 2) The main point in the complexity study, namely the functional programming component, is absent. The Editorial Board of the SIAM JC had been warned a confirmed publication would be openly commented,
arxiv
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers
ABSTRACT Objective To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of iluzanebart, a fully human monoclonal antibody TREM2 (triggering receptor expressed on myeloid cells 2) agonist, after single‐ (SAD) and multiple‐ascending‐dose (MAD) administration.
Andreas Meier+8 more
wiley +1 more source
Editorial for Volume 7, Number 1, June 2019.
The Editors
doaj +1 more source
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib+16 more
wiley +1 more source